Bigfoot Biomedical

About:

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.

Website: http://www.bigfootbiomedical.com

Twitter/X: BigfootBiomed

Top Investors: Abbott, Cormorant Asset Management, Janus Henderson Investors, Smile Group, Taiwania Capital Management Corporation

Description:

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.

Total Funding Amount:

$205M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Milpitas, California, United States

Founded Date:

2014-11-18

Contact Email:

info(AT)bigfootbiomedical.com

Founders:

Bryan Mazlish, Jeffrey Brewer, Jon Brilliant, Lane Desborough

Number of Employees:

101-250

Last Funding Date:

2022-08-15

IPO Status:

Private

© 2024 MyAiNote.com